Joint Filing AgreementJoint Filing Agreement • September 17th, 2019 • Kirk Randal J • Pharmaceutical preparations
Contract Type FiledSeptember 17th, 2019 Company IndustryIn accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Fibrocell Science, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 17th day of September, 2019.